Skeletal Morbidity in Children and Adolescents during and following Cancer Therapy
- PMID: 30481777
- PMCID: PMC6536370
- DOI: 10.1159/000494809
Skeletal Morbidity in Children and Adolescents during and following Cancer Therapy
Abstract
Skeletal abnormalities are common in children and adolescents diagnosed and treated for a malignancy. The spectrum ranges from mild pain to debilitating osteonecrosis and fractures. In this review, we summarize the impact of cancer therapy on the developing skeleton, provide an update on therapeutic strategies for prevention and treatment, and discuss the most recent advances in musculoskeletal research. Early recognition of skeletal abnormalities and strategies to optimize bone health are essential to prevent long-term skeletal sequelae and diminished quality of life in childhood cancer survivors.
Keywords: Acute lymphoblastic leukemia; Chemotherapy; Fractures; Hematopoietic stem cell transplantation; Osteochondroma; Osteonecrosis; Radiotherapy; Retinoids.
© 2018 S. Karger AG, Basel.
Conflict of interest statement
Figures
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
